ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Opioid Induced Constipation Drugs Market Research Report 2025
Published Date: August 2025
|
Report Code: QYRE-Auto-28I2111
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Opioid Induced Constipation Drugs Market Insights and Forecast to 2028
BUY CHAPTERS

Global Opioid Induced Constipation Drugs Market Research Report 2025

Code: QYRE-Auto-28I2111
Report
August 2025
Pages:103
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Ironwood Pharmaceuticals Inc
Daiichi Sankyo Co Ltd
Pfizer Inc
Progenics Pharmaceuticals, Inc.
Shionogi
Allergan plc
Nektar Therapeutics
Purdue Pharma
S.L.A. Pharma AG
Mundipharma International Limited
Ono Pharmaceutical Co Ltd
Takeda Pharmaceutical Company Limited
Theravance Biopharma Inc
Bausch Health
Cosmo Pharmaceuticals SA
Daewoong Pharmaceutical
C. B. Fleet Company
Sucampo Pharmaceuticals

Opioid Induced Constipation Drugs Market Size

The global market for Opioid Induced Constipation Drugs was valued at US$ 2775 million in the year 2024 and is projected to reach a revised size of US$ 3785 million by 2031, growing at a CAGR of 4.6% during the forecast period.

Opioid Induced Constipation Drugs Market

Opioid Induced Constipation Drugs Market

Although opioids are very effective for treating and managing pain, their use frequently results in opioid-induced constipation (OIC). Treatment options for OIC may be as simple as changing diet or as complicated as requiring several medicines and laxatives.
Global Opioid-Induced Constipation key players include Sanofi, Bayer, Purdue Pharm, etc. Global top three manufacturers hold a share over 45%.
North America is the largest market, with a share about 55%, followed by Europe, and Asia-Pacific, both have a share about 35 percent.
In terms of product, Lubiprostone is the largest segment, with a share about 5%. And in terms of application, the largest application is Pharmacy, followed by Hospital, etc.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Opioid Induced Constipation Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Opioid Induced Constipation Drugs.
The Opioid Induced Constipation Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Opioid Induced Constipation Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Opioid Induced Constipation Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Opioid Induced Constipation Drugs Market Report

Report Metric Details
Report Name Opioid Induced Constipation Drugs Market
Accounted market size in year US$ 2775 million
Forecasted market size in 2031 US$ 3785 million
CAGR 4.6%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Lubiprostone
  • Methyl Naltrexone Bromide
  • Naldemedine
  • Alvimopan
  • Others
Segment by Application
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Ironwood Pharmaceuticals Inc, Daiichi Sankyo Co Ltd, Pfizer, Progenics Pharmaceuticals Inc, Shionogi & Co., Ltd, Allergan Plc, Nektar Therapeutics, Purdue Pharma, S.L.A. Pharma AG, Mundipharma International Limited, Ono Pharmaceutical Co., Ltd, Takeda Pharmaceutical Company Limited, Theravance Biopharma Inc, Bausch Health, Cosmo Pharmaceuticals SA, Daewoong Pharmaceutical, C.B. Fleet Company, Sucampo Pharmaceuticals
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Opioid Induced Constipation Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Opioid Induced Constipation Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Opioid Induced Constipation Drugs Market growing?

Ans: The Opioid Induced Constipation Drugs Market witnessing a CAGR of 4.6% during the forecast period 2025-2031.

What is the Opioid Induced Constipation Drugs Market size in 2031?

Ans: The Opioid Induced Constipation Drugs Market size in 2031 will be US$ 3785 million.

What is the market share of major companies in Opioid Induced Constipation Drugs Market?

Ans: Global top three manufacturers hold a share over 45%.

What is the Opioid Induced Constipation Drugs Market share by type?

Ans: In terms of product, Lubiprostone is the largest segment, with a share about 5%.

Who are the main players in the Opioid Induced Constipation Drugs Market report?

Ans: The main players in the Opioid Induced Constipation Drugs Market are Ironwood Pharmaceuticals Inc, Daiichi Sankyo Co Ltd, Pfizer, Progenics Pharmaceuticals Inc, Shionogi & Co., Ltd, Allergan Plc, Nektar Therapeutics, Purdue Pharma, S.L.A. Pharma AG, Mundipharma International Limited, Ono Pharmaceutical Co., Ltd, Takeda Pharmaceutical Company Limited, Theravance Biopharma Inc, Bausch Health, Cosmo Pharmaceuticals SA, Daewoong Pharmaceutical, C.B. Fleet Company, Sucampo Pharmaceuticals

What are the Application segmentation covered in the Opioid Induced Constipation Drugs Market report?

Ans: The Applications covered in the Opioid Induced Constipation Drugs Market report are Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

What are the Type segmentation covered in the Opioid Induced Constipation Drugs Market report?

Ans: The Types covered in the Opioid Induced Constipation Drugs Market report are Lubiprostone, Methyl Naltrexone Bromide, Naldemedine, Alvimopan, Others

1 Opioid Induced Constipation Drugs Market Overview
1.1 Product Definition
1.2 Opioid Induced Constipation Drugs by Type
1.2.1 Global Opioid Induced Constipation Drugs Market Value Comparison by Type (2024 VS 2031)
1.2.2 Lubiprostone
1.2.3 Methyl Naltrexone Bromide
1.2.4 Naldemedine
1.2.5 Alvimopan
1.2.6 Others
1.3 Opioid Induced Constipation Drugs by Application
1.3.1 Global Opioid Induced Constipation Drugs Market Value by Application (2024 VS 2031)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global Opioid Induced Constipation Drugs Market Size Estimates and Forecasts
1.4.1 Global Opioid Induced Constipation Drugs Revenue 2020-2031
1.4.2 Global Opioid Induced Constipation Drugs Sales 2020-2031
1.4.3 Global Opioid Induced Constipation Drugs Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Opioid Induced Constipation Drugs Market Competition by Manufacturers
2.1 Global Opioid Induced Constipation Drugs Sales Market Share by Manufacturers (2020-2025)
2.2 Global Opioid Induced Constipation Drugs Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Opioid Induced Constipation Drugs Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Opioid Induced Constipation Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Opioid Induced Constipation Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Opioid Induced Constipation Drugs, Product Type & Application
2.7 Global Key Manufacturers of Opioid Induced Constipation Drugs, Date of Enter into This Industry
2.8 Global Opioid Induced Constipation Drugs Market Competitive Situation and Trends
2.8.1 Global Opioid Induced Constipation Drugs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Opioid Induced Constipation Drugs Players Market Share by Revenue
2.8.3 Global Opioid Induced Constipation Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Opioid Induced Constipation Drugs Market Scenario by Region
3.1 Global Opioid Induced Constipation Drugs Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Opioid Induced Constipation Drugs Sales by Region: 2020-2031
3.2.1 Global Opioid Induced Constipation Drugs Sales by Region: 2020-2025
3.2.2 Global Opioid Induced Constipation Drugs Sales by Region: 2026-2031
3.3 Global Opioid Induced Constipation Drugs Revenue by Region: 2020-2031
3.3.1 Global Opioid Induced Constipation Drugs Revenue by Region: 2020-2025
3.3.2 Global Opioid Induced Constipation Drugs Revenue by Region: 2026-2031
3.4 North America Opioid Induced Constipation Drugs Market Facts & Figures by Country
3.4.1 North America Opioid Induced Constipation Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Opioid Induced Constipation Drugs Sales by Country (2020-2031)
3.4.3 North America Opioid Induced Constipation Drugs Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Opioid Induced Constipation Drugs Market Facts & Figures by Country
3.5.1 Europe Opioid Induced Constipation Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Opioid Induced Constipation Drugs Sales by Country (2020-2031)
3.5.3 Europe Opioid Induced Constipation Drugs Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Opioid Induced Constipation Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Opioid Induced Constipation Drugs Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Opioid Induced Constipation Drugs Sales by Region (2020-2031)
3.6.3 Asia Pacific Opioid Induced Constipation Drugs Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Opioid Induced Constipation Drugs Market Facts & Figures by Country
3.7.1 Latin America Opioid Induced Constipation Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Opioid Induced Constipation Drugs Sales by Country (2020-2031)
3.7.3 Latin America Opioid Induced Constipation Drugs Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Opioid Induced Constipation Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Opioid Induced Constipation Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Opioid Induced Constipation Drugs Sales by Country (2020-2031)
3.8.3 Middle East and Africa Opioid Induced Constipation Drugs Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Opioid Induced Constipation Drugs Sales by Type (2020-2031)
4.1.1 Global Opioid Induced Constipation Drugs Sales by Type (2020-2025)
4.1.2 Global Opioid Induced Constipation Drugs Sales by Type (2026-2031)
4.1.3 Global Opioid Induced Constipation Drugs Sales Market Share by Type (2020-2031)
4.2 Global Opioid Induced Constipation Drugs Revenue by Type (2020-2031)
4.2.1 Global Opioid Induced Constipation Drugs Revenue by Type (2020-2025)
4.2.2 Global Opioid Induced Constipation Drugs Revenue by Type (2026-2031)
4.2.3 Global Opioid Induced Constipation Drugs Revenue Market Share by Type (2020-2031)
4.3 Global Opioid Induced Constipation Drugs Price by Type (2020-2031)
5 Segment by Application
5.1 Global Opioid Induced Constipation Drugs Sales by Application (2020-2031)
5.1.1 Global Opioid Induced Constipation Drugs Sales by Application (2020-2025)
5.1.2 Global Opioid Induced Constipation Drugs Sales by Application (2026-2031)
5.1.3 Global Opioid Induced Constipation Drugs Sales Market Share by Application (2020-2031)
5.2 Global Opioid Induced Constipation Drugs Revenue by Application (2020-2031)
5.2.1 Global Opioid Induced Constipation Drugs Revenue by Application (2020-2025)
5.2.2 Global Opioid Induced Constipation Drugs Revenue by Application (2026-2031)
5.2.3 Global Opioid Induced Constipation Drugs Revenue Market Share by Application (2020-2031)
5.3 Global Opioid Induced Constipation Drugs Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Ironwood Pharmaceuticals Inc
6.1.1 Ironwood Pharmaceuticals Inc Company Information
6.1.2 Ironwood Pharmaceuticals Inc Description and Business Overview
6.1.3 Ironwood Pharmaceuticals Inc Opioid Induced Constipation Drugs Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Ironwood Pharmaceuticals Inc Opioid Induced Constipation Drugs Product Portfolio
6.1.5 Ironwood Pharmaceuticals Inc Recent Developments/Updates
6.2 Daiichi Sankyo Co Ltd
6.2.1 Daiichi Sankyo Co Ltd Company Information
6.2.2 Daiichi Sankyo Co Ltd Description and Business Overview
6.2.3 Daiichi Sankyo Co Ltd Opioid Induced Constipation Drugs Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Daiichi Sankyo Co Ltd Opioid Induced Constipation Drugs Product Portfolio
6.2.5 Daiichi Sankyo Co Ltd Recent Developments/Updates
6.3 Pfizer
6.3.1 Pfizer Company Information
6.3.2 Pfizer Description and Business Overview
6.3.3 Pfizer Opioid Induced Constipation Drugs Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Pfizer Opioid Induced Constipation Drugs Product Portfolio
6.3.5 Pfizer Recent Developments/Updates
6.4 Progenics Pharmaceuticals Inc
6.4.1 Progenics Pharmaceuticals Inc Company Information
6.4.2 Progenics Pharmaceuticals Inc Description and Business Overview
6.4.3 Progenics Pharmaceuticals Inc Opioid Induced Constipation Drugs Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Progenics Pharmaceuticals Inc Opioid Induced Constipation Drugs Product Portfolio
6.4.5 Progenics Pharmaceuticals Inc Recent Developments/Updates
6.5 Shionogi & Co., Ltd
6.5.1 Shionogi & Co., Ltd Company Information
6.5.2 Shionogi & Co., Ltd Description and Business Overview
6.5.3 Shionogi & Co., Ltd Opioid Induced Constipation Drugs Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Shionogi & Co., Ltd Opioid Induced Constipation Drugs Product Portfolio
6.5.5 Shionogi & Co., Ltd Recent Developments/Updates
6.6 Allergan Plc
6.6.1 Allergan Plc Company Information
6.6.2 Allergan Plc Description and Business Overview
6.6.3 Allergan Plc Opioid Induced Constipation Drugs Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Allergan Plc Opioid Induced Constipation Drugs Product Portfolio
6.6.5 Allergan Plc Recent Developments/Updates
6.7 Nektar Therapeutics
6.7.1 Nektar Therapeutics Company Information
6.7.2 Nektar Therapeutics Description and Business Overview
6.7.3 Nektar Therapeutics Opioid Induced Constipation Drugs Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Nektar Therapeutics Opioid Induced Constipation Drugs Product Portfolio
6.7.5 Nektar Therapeutics Recent Developments/Updates
6.8 Purdue Pharma
6.8.1 Purdue Pharma Company Information
6.8.2 Purdue Pharma Description and Business Overview
6.8.3 Purdue Pharma Opioid Induced Constipation Drugs Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Purdue Pharma Opioid Induced Constipation Drugs Product Portfolio
6.8.5 Purdue Pharma Recent Developments/Updates
6.9 S.L.A. Pharma AG
6.9.1 S.L.A. Pharma AG Company Information
6.9.2 S.L.A. Pharma AG Description and Business Overview
6.9.3 S.L.A. Pharma AG Opioid Induced Constipation Drugs Sales, Revenue and Gross Margin (2020-2025)
6.9.4 S.L.A. Pharma AG Opioid Induced Constipation Drugs Product Portfolio
6.9.5 S.L.A. Pharma AG Recent Developments/Updates
6.10 Mundipharma International Limited
6.10.1 Mundipharma International Limited Company Information
6.10.2 Mundipharma International Limited Description and Business Overview
6.10.3 Mundipharma International Limited Opioid Induced Constipation Drugs Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Mundipharma International Limited Opioid Induced Constipation Drugs Product Portfolio
6.10.5 Mundipharma International Limited Recent Developments/Updates
6.11 Ono Pharmaceutical Co., Ltd
6.11.1 Ono Pharmaceutical Co., Ltd Company Information
6.11.2 Ono Pharmaceutical Co., Ltd Description and Business Overview
6.11.3 Ono Pharmaceutical Co., Ltd Opioid Induced Constipation Drugs Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Ono Pharmaceutical Co., Ltd Opioid Induced Constipation Drugs Product Portfolio
6.11.5 Ono Pharmaceutical Co., Ltd Recent Developments/Updates
6.12 Takeda Pharmaceutical Company Limited
6.12.1 Takeda Pharmaceutical Company Limited Company Information
6.12.2 Takeda Pharmaceutical Company Limited Description and Business Overview
6.12.3 Takeda Pharmaceutical Company Limited Opioid Induced Constipation Drugs Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Takeda Pharmaceutical Company Limited Opioid Induced Constipation Drugs Product Portfolio
6.12.5 Takeda Pharmaceutical Company Limited Recent Developments/Updates
6.13 Theravance Biopharma Inc
6.13.1 Theravance Biopharma Inc Company Information
6.13.2 Theravance Biopharma Inc Description and Business Overview
6.13.3 Theravance Biopharma Inc Opioid Induced Constipation Drugs Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Theravance Biopharma Inc Opioid Induced Constipation Drugs Product Portfolio
6.13.5 Theravance Biopharma Inc Recent Developments/Updates
6.14 Bausch Health
6.14.1 Bausch Health Company Information
6.14.2 Bausch Health Description and Business Overview
6.14.3 Bausch Health Opioid Induced Constipation Drugs Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Bausch Health Opioid Induced Constipation Drugs Product Portfolio
6.14.5 Bausch Health Recent Developments/Updates
6.15 Cosmo Pharmaceuticals SA
6.15.1 Cosmo Pharmaceuticals SA Company Information
6.15.2 Cosmo Pharmaceuticals SA Description and Business Overview
6.15.3 Cosmo Pharmaceuticals SA Opioid Induced Constipation Drugs Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Cosmo Pharmaceuticals SA Opioid Induced Constipation Drugs Product Portfolio
6.15.5 Cosmo Pharmaceuticals SA Recent Developments/Updates
6.16 Daewoong Pharmaceutical
6.16.1 Daewoong Pharmaceutical Company Information
6.16.2 Daewoong Pharmaceutical Description and Business Overview
6.16.3 Daewoong Pharmaceutical Opioid Induced Constipation Drugs Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Daewoong Pharmaceutical Opioid Induced Constipation Drugs Product Portfolio
6.16.5 Daewoong Pharmaceutical Recent Developments/Updates
6.17 C.B. Fleet Company
6.17.1 C.B. Fleet Company Company Information
6.17.2 C.B. Fleet Company Description and Business Overview
6.17.3 C.B. Fleet Company Opioid Induced Constipation Drugs Sales, Revenue and Gross Margin (2020-2025)
6.17.4 C.B. Fleet Company Opioid Induced Constipation Drugs Product Portfolio
6.17.5 C.B. Fleet Company Recent Developments/Updates
6.18 Sucampo Pharmaceuticals
6.18.1 Sucampo Pharmaceuticals Company Information
6.18.2 Sucampo Pharmaceuticals Description and Business Overview
6.18.3 Sucampo Pharmaceuticals Opioid Induced Constipation Drugs Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Sucampo Pharmaceuticals Opioid Induced Constipation Drugs Product Portfolio
6.18.5 Sucampo Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Opioid Induced Constipation Drugs Industry Chain Analysis
7.2 Opioid Induced Constipation Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Opioid Induced Constipation Drugs Production Mode & Process Analysis
7.4 Opioid Induced Constipation Drugs Sales and Marketing
7.4.1 Opioid Induced Constipation Drugs Sales Channels
7.4.2 Opioid Induced Constipation Drugs Distributors
7.5 Opioid Induced Constipation Drugs Customer Analysis
8 Opioid Induced Constipation Drugs Market Dynamics
8.1 Opioid Induced Constipation Drugs Industry Trends
8.2 Opioid Induced Constipation Drugs Market Drivers
8.3 Opioid Induced Constipation Drugs Market Challenges
8.4 Opioid Induced Constipation Drugs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Ironwood Pharmaceuticals Inc
Daiichi Sankyo Co Ltd
Pfizer Inc
Progenics Pharmaceuticals, Inc.
Shionogi
Allergan plc
Nektar Therapeutics
Purdue Pharma
S.L.A. Pharma AG
Mundipharma International Limited
Ono Pharmaceutical Co Ltd
Takeda Pharmaceutical Company Limited
Theravance Biopharma Inc
Bausch Health
Cosmo Pharmaceuticals SA
Daewoong Pharmaceutical
C. B. Fleet Company
Sucampo Pharmaceuticals
List of Tables
 Table 1. Global Opioid Induced Constipation Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Opioid Induced Constipation Drugs Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Opioid Induced Constipation Drugs Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Opioid Induced Constipation Drugs Sales (K Pcs) of Key Manufacturers (2020-2025)
 Table 5. Global Opioid Induced Constipation Drugs Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Opioid Induced Constipation Drugs Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Opioid Induced Constipation Drugs Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Opioid Induced Constipation Drugs Average Price (USD/Pcs) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Opioid Induced Constipation Drugs, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Opioid Induced Constipation Drugs, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Opioid Induced Constipation Drugs, Product Type & Application
 Table 12. Global Key Manufacturers of Opioid Induced Constipation Drugs, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Opioid Induced Constipation Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Opioid Induced Constipation Drugs as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Opioid Induced Constipation Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Opioid Induced Constipation Drugs Sales by Region (2020-2025) & (K Pcs)
 Table 18. Global Opioid Induced Constipation Drugs Sales Market Share by Region (2020-2025)
 Table 19. Global Opioid Induced Constipation Drugs Sales by Region (2026-2031) & (K Pcs)
 Table 20. Global Opioid Induced Constipation Drugs Sales Market Share by Region (2026-2031)
 Table 21. Global Opioid Induced Constipation Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Opioid Induced Constipation Drugs Revenue Market Share by Region (2020-2025)
 Table 23. Global Opioid Induced Constipation Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Opioid Induced Constipation Drugs Revenue Market Share by Region (2026-2031)
 Table 25. North America Opioid Induced Constipation Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Opioid Induced Constipation Drugs Sales by Country (2020-2025) & (K Pcs)
 Table 27. North America Opioid Induced Constipation Drugs Sales by Country (2026-2031) & (K Pcs)
 Table 28. North America Opioid Induced Constipation Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Opioid Induced Constipation Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Opioid Induced Constipation Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Opioid Induced Constipation Drugs Sales by Country (2020-2025) & (K Pcs)
 Table 32. Europe Opioid Induced Constipation Drugs Sales by Country (2026-2031) & (K Pcs)
 Table 33. Europe Opioid Induced Constipation Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Opioid Induced Constipation Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Opioid Induced Constipation Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Opioid Induced Constipation Drugs Sales by Region (2020-2025) & (K Pcs)
 Table 37. Asia Pacific Opioid Induced Constipation Drugs Sales by Region (2026-2031) & (K Pcs)
 Table 38. Asia Pacific Opioid Induced Constipation Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Opioid Induced Constipation Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Opioid Induced Constipation Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Opioid Induced Constipation Drugs Sales by Country (2020-2025) & (K Pcs)
 Table 42. Latin America Opioid Induced Constipation Drugs Sales by Country (2026-2031) & (K Pcs)
 Table 43. Latin America Opioid Induced Constipation Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Opioid Induced Constipation Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Opioid Induced Constipation Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Opioid Induced Constipation Drugs Sales by Country (2020-2025) & (K Pcs)
 Table 47. Middle East and Africa Opioid Induced Constipation Drugs Sales by Country (2026-2031) & (K Pcs)
 Table 48. Middle East and Africa Opioid Induced Constipation Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Opioid Induced Constipation Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Opioid Induced Constipation Drugs Sales (K Pcs) by Type (2020-2025)
 Table 51. Global Opioid Induced Constipation Drugs Sales (K Pcs) by Type (2026-2031)
 Table 52. Global Opioid Induced Constipation Drugs Sales Market Share by Type (2020-2025)
 Table 53. Global Opioid Induced Constipation Drugs Sales Market Share by Type (2026-2031)
 Table 54. Global Opioid Induced Constipation Drugs Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Opioid Induced Constipation Drugs Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Opioid Induced Constipation Drugs Revenue Market Share by Type (2020-2025)
 Table 57. Global Opioid Induced Constipation Drugs Revenue Market Share by Type (2026-2031)
 Table 58. Global Opioid Induced Constipation Drugs Price (USD/Pcs) by Type (2020-2025)
 Table 59. Global Opioid Induced Constipation Drugs Price (USD/Pcs) by Type (2026-2031)
 Table 60. Global Opioid Induced Constipation Drugs Sales (K Pcs) by Application (2020-2025)
 Table 61. Global Opioid Induced Constipation Drugs Sales (K Pcs) by Application (2026-2031)
 Table 62. Global Opioid Induced Constipation Drugs Sales Market Share by Application (2020-2025)
 Table 63. Global Opioid Induced Constipation Drugs Sales Market Share by Application (2026-2031)
 Table 64. Global Opioid Induced Constipation Drugs Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Opioid Induced Constipation Drugs Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Opioid Induced Constipation Drugs Revenue Market Share by Application (2020-2025)
 Table 67. Global Opioid Induced Constipation Drugs Revenue Market Share by Application (2026-2031)
 Table 68. Global Opioid Induced Constipation Drugs Price (USD/Pcs) by Application (2020-2025)
 Table 69. Global Opioid Induced Constipation Drugs Price (USD/Pcs) by Application (2026-2031)
 Table 70. Ironwood Pharmaceuticals Inc Company Information
 Table 71. Ironwood Pharmaceuticals Inc Description and Business Overview
 Table 72. Ironwood Pharmaceuticals Inc Opioid Induced Constipation Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 73. Ironwood Pharmaceuticals Inc Opioid Induced Constipation Drugs Product
 Table 74. Ironwood Pharmaceuticals Inc Recent Developments/Updates
 Table 75. Daiichi Sankyo Co Ltd Company Information
 Table 76. Daiichi Sankyo Co Ltd Description and Business Overview
 Table 77. Daiichi Sankyo Co Ltd Opioid Induced Constipation Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 78. Daiichi Sankyo Co Ltd Opioid Induced Constipation Drugs Product
 Table 79. Daiichi Sankyo Co Ltd Recent Developments/Updates
 Table 80. Pfizer Company Information
 Table 81. Pfizer Description and Business Overview
 Table 82. Pfizer Opioid Induced Constipation Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 83. Pfizer Opioid Induced Constipation Drugs Product
 Table 84. Pfizer Recent Developments/Updates
 Table 85. Progenics Pharmaceuticals Inc Company Information
 Table 86. Progenics Pharmaceuticals Inc Description and Business Overview
 Table 87. Progenics Pharmaceuticals Inc Opioid Induced Constipation Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 88. Progenics Pharmaceuticals Inc Opioid Induced Constipation Drugs Product
 Table 89. Progenics Pharmaceuticals Inc Recent Developments/Updates
 Table 90. Shionogi & Co., Ltd Company Information
 Table 91. Shionogi & Co., Ltd Description and Business Overview
 Table 92. Shionogi & Co., Ltd Opioid Induced Constipation Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 93. Shionogi & Co., Ltd Opioid Induced Constipation Drugs Product
 Table 94. Shionogi & Co., Ltd Recent Developments/Updates
 Table 95. Allergan Plc Company Information
 Table 96. Allergan Plc Description and Business Overview
 Table 97. Allergan Plc Opioid Induced Constipation Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 98. Allergan Plc Opioid Induced Constipation Drugs Product
 Table 99. Allergan Plc Recent Developments/Updates
 Table 100. Nektar Therapeutics Company Information
 Table 101. Nektar Therapeutics Description and Business Overview
 Table 102. Nektar Therapeutics Opioid Induced Constipation Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 103. Nektar Therapeutics Opioid Induced Constipation Drugs Product
 Table 104. Nektar Therapeutics Recent Developments/Updates
 Table 105. Purdue Pharma Company Information
 Table 106. Purdue Pharma Description and Business Overview
 Table 107. Purdue Pharma Opioid Induced Constipation Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 108. Purdue Pharma Opioid Induced Constipation Drugs Product
 Table 109. Purdue Pharma Recent Developments/Updates
 Table 110. S.L.A. Pharma AG Company Information
 Table 111. S.L.A. Pharma AG Description and Business Overview
 Table 112. S.L.A. Pharma AG Opioid Induced Constipation Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 113. S.L.A. Pharma AG Opioid Induced Constipation Drugs Product
 Table 114. S.L.A. Pharma AG Recent Developments/Updates
 Table 115. Mundipharma International Limited Company Information
 Table 116. Mundipharma International Limited Description and Business Overview
 Table 117. Mundipharma International Limited Opioid Induced Constipation Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 118. Mundipharma International Limited Opioid Induced Constipation Drugs Product
 Table 119. Mundipharma International Limited Recent Developments/Updates
 Table 120. Ono Pharmaceutical Co., Ltd Company Information
 Table 121. Ono Pharmaceutical Co., Ltd Description and Business Overview
 Table 122. Ono Pharmaceutical Co., Ltd Opioid Induced Constipation Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 123. Ono Pharmaceutical Co., Ltd Opioid Induced Constipation Drugs Product
 Table 124. Ono Pharmaceutical Co., Ltd Recent Developments/Updates
 Table 125. Takeda Pharmaceutical Company Limited Company Information
 Table 126. Takeda Pharmaceutical Company Limited Description and Business Overview
 Table 127. Takeda Pharmaceutical Company Limited Opioid Induced Constipation Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 128. Takeda Pharmaceutical Company Limited Opioid Induced Constipation Drugs Product
 Table 129. Takeda Pharmaceutical Company Limited Recent Developments/Updates
 Table 130. Theravance Biopharma Inc Company Information
 Table 131. Theravance Biopharma Inc Description and Business Overview
 Table 132. Theravance Biopharma Inc Opioid Induced Constipation Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 133. Theravance Biopharma Inc Opioid Induced Constipation Drugs Product
 Table 134. Theravance Biopharma Inc Recent Developments/Updates
 Table 135. Bausch Health Company Information
 Table 136. Bausch Health Description and Business Overview
 Table 137. Bausch Health Opioid Induced Constipation Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 138. Bausch Health Opioid Induced Constipation Drugs Product
 Table 139. Bausch Health Recent Developments/Updates
 Table 140. Cosmo Pharmaceuticals SA Company Information
 Table 141. Cosmo Pharmaceuticals SA Description and Business Overview
 Table 142. Cosmo Pharmaceuticals SA Opioid Induced Constipation Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 143. Cosmo Pharmaceuticals SA Opioid Induced Constipation Drugs Product
 Table 144. Cosmo Pharmaceuticals SA Recent Developments/Updates
 Table 145. Daewoong Pharmaceutical Company Information
 Table 146. Daewoong Pharmaceutical Description and Business Overview
 Table 147. Daewoong Pharmaceutical Opioid Induced Constipation Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 148. Daewoong Pharmaceutical Opioid Induced Constipation Drugs Product
 Table 149. Daewoong Pharmaceutical Recent Developments/Updates
 Table 150. C.B. Fleet Company Company Information
 Table 151. C.B. Fleet Company Description and Business Overview
 Table 152. C.B. Fleet Company Opioid Induced Constipation Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 153. C.B. Fleet Company Opioid Induced Constipation Drugs Product
 Table 154. C.B. Fleet Company Recent Developments/Updates
 Table 155. Sucampo Pharmaceuticals Company Information
 Table 156. Sucampo Pharmaceuticals Description and Business Overview
 Table 157. Sucampo Pharmaceuticals Opioid Induced Constipation Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 158. Sucampo Pharmaceuticals Opioid Induced Constipation Drugs Product
 Table 159. Sucampo Pharmaceuticals Recent Developments/Updates
 Table 160. Key Raw Materials Lists
 Table 161. Raw Materials Key Suppliers Lists
 Table 162. Opioid Induced Constipation Drugs Distributors List
 Table 163. Opioid Induced Constipation Drugs Customers List
 Table 164. Opioid Induced Constipation Drugs Market Trends
 Table 165. Opioid Induced Constipation Drugs Market Drivers
 Table 166. Opioid Induced Constipation Drugs Market Challenges
 Table 167. Opioid Induced Constipation Drugs Market Restraints
 Table 168. Research Programs/Design for This Report
 Table 169. Key Data Information from Secondary Sources
 Table 170. Key Data Information from Primary Sources
 Table 171. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Opioid Induced Constipation Drugs
 Figure 2. Global Opioid Induced Constipation Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Opioid Induced Constipation Drugs Market Share by Type: 2024 & 2031
 Figure 4. Lubiprostone Product Picture
 Figure 5. Methyl Naltrexone Bromide Product Picture
 Figure 6. Naldemedine Product Picture
 Figure 7. Alvimopan Product Picture
 Figure 8. Others Product Picture
 Figure 9. Global Opioid Induced Constipation Drugs Market Value by Application (2020-2031) & (US$ Million)
 Figure 10. Global Opioid Induced Constipation Drugs Market Share by Application: 2024 & 2031
 Figure 11. Hospital Pharmacies
 Figure 12. Retail Pharmacies
 Figure 13. Online Pharmacies
 Figure 14. Global Opioid Induced Constipation Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Opioid Induced Constipation Drugs Market Size (2020-2031) & (US$ Million)
 Figure 16. Global Opioid Induced Constipation Drugs Sales (2020-2031) & (K Pcs)
 Figure 17. Global Opioid Induced Constipation Drugs Average Price (USD/Pcs) & (2020-2031)
 Figure 18. Opioid Induced Constipation Drugs Report Years Considered
 Figure 19. Opioid Induced Constipation Drugs Sales Share by Manufacturers in 2024
 Figure 20. Global Opioid Induced Constipation Drugs Revenue Share by Manufacturers in 2024
 Figure 21. Global 5 and 10 Largest Opioid Induced Constipation Drugs Players: Market Share by Revenue in Opioid Induced Constipation Drugs in 2024
 Figure 22. Opioid Induced Constipation Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 23. Global Opioid Induced Constipation Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 24. North America Opioid Induced Constipation Drugs Sales Market Share by Country (2020-2031)
 Figure 25. North America Opioid Induced Constipation Drugs Revenue Market Share by Country (2020-2031)
 Figure 26. U.S. Opioid Induced Constipation Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Canada Opioid Induced Constipation Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Europe Opioid Induced Constipation Drugs Sales Market Share by Country (2020-2031)
 Figure 29. Europe Opioid Induced Constipation Drugs Revenue Market Share by Country (2020-2031)
 Figure 30. Germany Opioid Induced Constipation Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. France Opioid Induced Constipation Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. U.K. Opioid Induced Constipation Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Italy Opioid Induced Constipation Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Russia Opioid Induced Constipation Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Asia Pacific Opioid Induced Constipation Drugs Sales Market Share by Region (2020-2031)
 Figure 36. Asia Pacific Opioid Induced Constipation Drugs Revenue Market Share by Region (2020-2031)
 Figure 37. China Opioid Induced Constipation Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Japan Opioid Induced Constipation Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. South Korea Opioid Induced Constipation Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. India Opioid Induced Constipation Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Australia Opioid Induced Constipation Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Taiwan Opioid Induced Constipation Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Indonesia Opioid Induced Constipation Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Thailand Opioid Induced Constipation Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Malaysia Opioid Induced Constipation Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Philippines Opioid Induced Constipation Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Latin America Opioid Induced Constipation Drugs Sales Market Share by Country (2020-2031)
 Figure 48. Latin America Opioid Induced Constipation Drugs Revenue Market Share by Country (2020-2031)
 Figure 49. Mexico Opioid Induced Constipation Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Brazil Opioid Induced Constipation Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Argentina Opioid Induced Constipation Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Middle East and Africa Opioid Induced Constipation Drugs Sales Market Share by Country (2020-2031)
 Figure 53. Middle East and Africa Opioid Induced Constipation Drugs Revenue Market Share by Country (2020-2031)
 Figure 54. Turkey Opioid Induced Constipation Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Saudi Arabia Opioid Induced Constipation Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. U.A.E Opioid Induced Constipation Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 57. Global Sales Market Share of Opioid Induced Constipation Drugs by Type (2020-2031)
 Figure 58. Global Revenue Market Share of Opioid Induced Constipation Drugs by Type (2020-2031)
 Figure 59. Global Opioid Induced Constipation Drugs Price (USD/Pcs) by Type (2020-2031)
 Figure 60. Global Sales Market Share of Opioid Induced Constipation Drugs by Application (2020-2031)
 Figure 61. Global Revenue Market Share of Opioid Induced Constipation Drugs by Application (2020-2031)
 Figure 62. Global Opioid Induced Constipation Drugs Price (USD/Pcs) by Application (2020-2031)
 Figure 63. Opioid Induced Constipation Drugs Value Chain
 Figure 64. Channels of Distribution (Direct Vs Distribution)
 Figure 65. Bottom-up and Top-down Approaches for This Report
 Figure 66. Data Triangulation
 Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

Global Opioid Induced Constipation OIC Drugs Market Research Report 2024
Global Opioid Induced Constipation Market Size Manufacturers Supply Chain Sales Channel and Clients 2024 2030
Global Opioid Withdrawal Treatment Market Insights Forecast to 2030
Global Constipation Treatment Drug Market Research Report 2025
Global Opioid Drugs Market Insights Forecast to 2030
Opioid Induced Side Effects Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Opioid Use Disorder Market Insights Forecast to 2030
Global Opioids Drug Market Research Report 2025
Global Gastrointestinal OTC Drugs Market Research Report 2024
Global Chronic Idiopathic Constipation Drugs Market Research Report 2024
Global Opioid Narcotics Market Research Report 2024
Global Chronic Constipation Treatment Drugs Market Research Report 2024
Opioids Agonist Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Synthetic Opioids Market Research Report 2024
Global OAB Treatment Market Research Report 2025
Global Stool Softeners Market Research Report 2024
Global Prescription Gastrointestinal Drugs Market Research Report 2024
Opioids Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Opioid Use Disorder Treatment Market Research Report 2024
Global Digestive Drugs Market Insights Forecast to 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions